Dr. Sanjay Khanna

I am a Medical Oncology Registrar on the UK’s first dual-accredited training pathway—the first registrar permitted to combine clinical specialty training with a substantive industry role.

Over 6 years at Roche, I have worked across the pharmaceutical value chain: Medical Affairs, regulatory submissions, clinical development (serving as second-in-command for an 80,000-participant blood-based early detection trial), and strategic partnering. I spent three years as a portfolio mentor for the Cambridge accelerator StartCodon.

My current industry-funded MD(Res) at the Royal Marsden Hospital and Institute of Cancer Research focuses on:

• U-RESPOND Study: Qualitative research using choice architecture to understand cancer screening behaviours
• Microsimulation Modelling: Testing population impact of blood-based screening in the UK
• LLM-based Decision Support: Building AI tools for cancer screening—designed for equity, scalability, and real-world implementation

I am building the evidence base for evaluating patient-facing AI and continue to publish on health policy and cancer regulation.